- Home
- Acute myeloid leukaemia (AML)
- Diagnosis
AML diagnosis
If you have symptoms of acute leukaemia, or if you have a test for another reason and it suggests acute leukaemia, your general practitioner (GP) will do a physical examination, organise further tests and may refer you to a specialist called a haematologist.
Learn more about:
Overview
A combination of blood and bone marrow tests will help your doctor confirm the diagnosis and work out the subtype of AML you have. You may have other tests to find out more about the AML, your general health and how well your organs are working.
After an AML diagnosis, you are likely to see a range of health professionals, who will all play a part in your treatment.
Many people feel understandably shocked and upset when told they have ALL. If you need support, call Cancer Council 13 11 20.
Podcast: Tests and Cancer
Listen to more of our podcast for people affected by cancer
More resources
Dr Jonathan Sillar, Haematologist, Calvary Mater Newcastle Hospital; Dr Scott Dunkley, Haematologist, Royal Prince Alfred Hospital and Chris O’Brien Lifehouse; Sharon Frazer, Consumer; Dr Robin Gasiorowski, Staff Specialist, Haematology, Concord Hospital; Prof Angela Hong, Radiation Oncologist, Chris O’Brien Lifehouse, and Clinical Professor, The University of Sydney; Yvonne King, 13 11 20 Consultant, Cancer Council NSW; Heather Mackay, Clinical Nurse Consultant – Haematology, Westmead Hospital; Katelin Mayer, Clinical Nurse Consultant, Cancer Outreach Team, Nelune Comprehensive Cancer Centre.
View the Cancer Council NSW editorial policy.
View all publications or call 13 11 20 for free printed copies.
Need to talk?
Support services
Coping with cancer?
Talk or email someone about symptoms or dealing with a diagnosis
Looking for transport or accommodation?
Help with getting to tests or finding a place to sleep
Cancer information
Dealing with the diagnosis
Common reactions to a cancer diagnosis and how to find hope
Blood cancers
Learn about the other blood cancers, such as acute lymphoblastic, chronic lymphocytic, chronic myeloid, Hodgkin lymphoma, and non-Hodgkin lymphoma